Sign in

Back to the bill

89th General Assembly · Iowa Funnel one-pager · Monday, November 9, 2026

SSB 3122: SSB 3122

Became SF 2345 · Its progress continues under the new number.

Sponsors

Not listed

Cost

See the fiscal note

1 million. Operating costs to continue administering the three additional tests are estimated to be approximately $714,000 per year. 80.

Senate subcommittee · named February 8, 2022

  • Sen. Mark Costello (R) · mark.costello@legis.iowa.gov
  • Sen. Jesse Green (R) · jesse.green@legis.iowa.gov
  • Sen. Sarah Trone Garriott (D) · sarah.trone.garriott@legis.iowa.gov

Lobbying · 13 for, 0 against

For: Every Life Foundation for Rare Diseases; EveryStep; Genentech, Inc., A Member of the Roche Group; Iowa Biotechnology Association; Iowa Chapter of the National Association of Pediatric Nurse Practitioners; Iowa Developmental Disabilities Council; Iowa Nurse Practitioners Society; Pfizer Inc. c/o Politicom Law LLP; Sanofi US; The Family Leader; The Family Leader Foundation; Ultragenyx Pharmaceutical Inc.; and 1 more

In plain words

  1. February 8, 2022Filed in the Senate and sent to the Human Resources committee
  2. February 8, 2022Senate subcommittee named: Costello, Green and Trone Garriott
  3. February 10, 2022Subcommittee recommended passing it with changes
  4. February 17, 2022Approved by the Senate committee, and given a new number: SF 2345

From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/89/SSB3122